Boston Scientific's heart stent wins approval in Canada

04/26/2012 | Reuters

Boston Scientific has received approval from Health Canada for its PROMUS Element Plus stent and plans to start marketing the device there immediately. The device, designed to treat patients with coronary artery disease, improves on the company's existing stent with a better-performing catheter delivery system.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI